본문 바로가기
KERD
논문KCI 등재

Management of Candida Urinary Tract Infection in the Elderly

Seung Ok Yang|Sang Jin Kim|Jae Hyun Ryu|Yun Beom Kim
대한요로생식기감염학회|2019.08|Urogenital Tract Infection|제14권 제2호|pp. 33-41|DOI 10.14777/uti.2019.14.2.33

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

Disease managementUrinary tract infectionsCandidaFrail elderly
주제분류비뇨기과학

초록

Candida urinary tract infections in elderly patients are becoming increasingly common. The risk factors for the development of candiduria include old age, use of broad-spectrum antibiotics, corticosteroids and indwelling urethral catheters, as well as diabetes mellitus, urological abnormalities, and hematological malig-nancies. The presence of signs and symptoms of infection are unusual, and the intensity of fungal growth in culture does not correlate with the outcome. Elderly patients often present with atypical signs and symptoms of infection. Careful assessment of the patient’s clinical status should be undertaken before treatment is initiated. The indications for antifungal therapy are the same for older and younger individuals, and the initial antifungal therapy should be selected based on the infecting organism and local epidemiology. Fluconazole is the mainstay of treat-ment. On the other hand, Candida glabrata is more common in elderly patients and is often refractory to fluconazole therapy. The selection of drug therapy for elderly patients should consider the comorbidities, risk of drug-drug interactions, and dose adjustment for physiological function.

Abstract

Candida urinary tract infections in elderly patients are becoming increasingly common. The risk factors for the development of candiduria include old age, use of broad-spectrum antibiotics, corticosteroids and indwelling urethral catheters, as well as diabetes mellitus, urological abnormalities, and hematological malig-nancies. The presence of signs and symptoms of infection are unusual, and the intensity of fungal growth in culture does not correlate with the outcome. Elderly patients often present with atypical signs and symptoms of infection. Careful assessment of the patient’s clinical status should be undertaken before treatment is initiated. The indications for antifungal therapy are the same for older and younger individuals, and the initial antifungal therapy should be selected based on the infecting organism and local epidemiology. Fluconazole is the mainstay of treat-ment. On the other hand, Candida glabrata is more common in elderly patients and is often refractory to fluconazole therapy. The selection of drug therapy for elderly patients should consider the comorbidities, risk of drug-drug interactions, and dose adjustment for physiological function.

참고문헌 (64)

  1. Rivett AG, "Urinary candidiasis : a prospective study in hospital patients", Urol Res, 14, pp.183~186 (1986)
  2. Hamory BH, "Hospital-associated candiduria : predisposing factors and review of the literature", J Urol, 120, pp.444~448 (1978)
  3. Kauffman CA, "Prospective multicenter surveillance study of funguria in hospitalized patients", Clin Infect Dis, 30, pp.14~18 (2000)
  4. Ayeni O, "Clinicians' reaction to positive urine culture for Candida organisms", Mycoses, 42, pp.285~289 (1999)
  5. Storfer SP, "Candiduria : retrospective review in hospitalized patients", Infect Dis Clin Pract, 3, pp.23~29 (1994)
  6. Harris AD, "Risk factors for nosocomial candiduria due to Candida glabrata and Candida albicans", Clin Infect Dis, 29, pp.926~928 (1999)
  7. Jacobs LG, "Fungal urinary tract infections in the elderly : treatment guidelines", Drugs Aging, 8, pp.89~96 (1996)
  8. Kauffman CA, "Fungal infections in older adults", Clin Infect Dis, 33, pp.550~555 (2001)
  9. Pfaller MA, "Epidemiology of invasive candidiasis : a persistent public health problem", Clin Microbiol Rev, 20, pp.133~163 (2007)
  10. Dimopoulos G, "Efficacy and safety of anidulafungin in elderly, critically ill patients with invasive Candida infections: a post hoc analysis", Int J Antimicrob Agents, 40, pp.521~526 (2012)
  11. Flevari A, "Treatment of invasive candidiasis in the elderly : a review", Clin Interv Aging, 8, pp.1199~1208 (2013)
  12. Bouza E, "Cooperative Group of the European Study Group on Nosocomial Infections. A European perspective on nosocomial urinary tract infections I. Report on the microbiology workload, etiology and antimicrobial susceptibility (ESGNI-003 study). European Study Group on Nosocomial Infections", Clin Microbiol Infect, 7, pp.523~531 (2001)
  13. Sobel JD, "Candida urinary tract infections--epidemiology", Clin Infect Dis, 52(Suppl 6), pp.S433~S436 (2011)
  14. Kobayashi CC, "Candiduria in hospital patients : a study prospective", Mycopathologia, 158, pp.49~52 (2004)
  15. Safdar N, "Predictors and outcomes of candiduria in renal transplant recipients", Clin Infect Dis, 40, pp.1413~1421 (2005)
  16. Nguyen MH, "The changing face of candidemia : emergence of non-Candida albicans species and antifungal resistance", Am J Med, 100, pp.617~623 (1996)
  17. Malani PN, "Trends in species causing fungaemia in a tertiary care medical centre over 12years", Mycoses, 44, pp.446~449 (2001)
  18. Pfaller MA, "Role of sentinel surveillance of candidemia : trends in species distribution and antifungal susceptibility", J Clin Microbiol, 40, pp.3551~3557 (2002)
  19. Pfaller MA, "Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000", J Clin Microbiol, 40, pp.852~856 (2002)
  20. Guinea J, "Global trends in the distribution of Candida species causing candidemia", Clin Microbiol Infect, 20(Suppl 6), pp.5~10 (2014)
  21. Malani A, "Candida glabrata fungemia : experience in a tertiary care center", Clin Infect Dis, 41, pp.975~981 (2005)
  22. Phillips JR, "Prevalence of Candida species in hospital-acquired urinary tract infections in a neonatal intensive care unit", Pediatr Infect Dis J, 16, pp.190~194 (1997)
  23. Kauffman CA, "Diagnosis and management of fungal urinary tract infection", Infect Dis Clin North Am, 28, pp.61~74 (2014)
  24. Hof H, "Candida infections in the elderly", Z GerontolGeriatr, 46, pp.64~70 (2013)[DOI]
  25. Aw D, "Is thymocyte development functional in the aged?", Aging (Albany NY), 1, pp.146~153 (2009)
  26. Colonna-Romano G, "B cells compartment in centenarian offspring and old people", Curr Pharm Des, 16, pp.604~608 (2010)
  27. Deray G., "Amphotericin B nephrotoxicity", J Antimicrob Chemother, 49(Suppl 1), pp.S37~S41 (2002)
  28. Stine JG, "Drug-induced liver injury in the elderly", Curr Gastroenterol Rep, 15, pp.299~ (2013)
  29. Woodhouse K, "Age-related changes in hepatic function. Implications for drug therapy", Drugs Aging, 2, pp.243~255 (1992)
  30. Tulner LR, "Discrepancies in reported drug use in geriatric outpatients : relevance to adverse events and drugdrug interactions", Am J Geriatr Pharmacother, 7, pp.93~104 (2009)
  31. Fick DM, "Updating the Beers criteria for potentially inappropriate medication use in older adults : results of a US consensus panel of experts", Arch Intern Med, 163, pp.2716~2724 (2003)
  32. Gallagher P, "Inappropriate prescribing in the elderly", J Clin Pharm Ther, 32, pp.113~121 (2007)
  33. Wey SB, "Risk factors for hospital-acquired candidemia. A matched casecontrol study", Arch Intern Med, 149, pp.2349~2353 (1989)
  34. Fisher JF, "Candida urinary tract infection: pathogenesis", Clin Infect Dis, 52(Suppl 6), pp.S437~S451 (2011)
  35. MacCallum DM, "Temporal events in the intravenous challenge model for experimental Candida albicans infections in female mice", Mycoses, 48, pp.151~161 (2005)
  36. Kauffman CA, "Candiduria", Clin Infect Dis, 41(Suppl 6), pp.S371~S376 (2005)
  37. Achkar JM, "Candida infections of the genitourinary tract", Clin Microbiol Rev, 23, pp.253~273 (2010)
  38. Siddique MS, "Salient features of Candida pyelonephritis in adults", Infect Dis Clin Pract, 1, pp.240~245 (1992)
  39. Tambyah PA, "Catheter-associated urinary tract infection is rarely symptomatic: a prospective study of 1,497catheterized patients", Arch Intern Med, 160, pp.678~682 (2000)
  40. 유재형, "Bacterial Urosepsis by a Fungal Ball Mimicking a Ureteral Stone", Urogenital Tract Infection, 9(2), pp.115~118 (2014), 대한요로생식기감염학회
  41. Jacobs LG, "Bladder irrigation with amphotericin B for treatment of fungal urinary tract infections", Clin Infect Dis, 18, pp.313~318 (1994)
  42. Fisher JF, "Yeast in the urine : solutions for a budding problem", Clin Infect Dis, 20, pp.183~189 (1995)
  43. Bougnoux ME, "CandiRea Study Group. Candidemia and candiduria in critically ill patients admitted to intensive care units in France: incidence, molecular diversity, management and outcome", Intensive Care Med, 34, pp.292~299 (2008)
  44. Drogari-Apiranthitou M, "Association between candiduria and candidemia : a clinical and molecular analysis of cases", Mycopathologia, 182, pp.1045~1052 (2017)
  45. Sobel JD, "Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo", Clin Infect Dis, 30, pp.19~24 (2000)
  46. Ang BS, "Candidemia from a urinary tract source : microbiological aspects and clinical significance", Clin Infect Dis, 17, pp.662~666 (1993)
  47. Gross M, "Unexpected candidemia complicating ureteroscopy and urinary stenting", Eur J Clin Microbiol Infect Dis, 17, pp.583~586 (1998)
  48. Pappas PG, "Infectious Diseases Society of America. Clinical practice guidelines for the management of candidiasis:2009 update by the Infectious Diseases Society of America", Clin Infect Dis, 48, pp.503~535 (2009)
  49. 양승옥, "카테터연관 요로감염", Urogenital Tract Infection, 8(2), pp.73~82 (2013), 대한요로생식기감염학회
  50. Auger P, "A study of 666 strains of Candida albicans : correlation between serotype and susceptibility to 5-fluorocytosine", J Infect Dis, 139, pp.590~594 (1979)
  51. Fisher JF, "Candida urinary tract infections--treatment", Clin Infect Dis, 52(Suppl 6), pp.S457~S466 (2011)
  52. Goldman HJ, "Monilial cystitis-effective treatment with instilations of amphotericin B", JAMA, 174, pp.359~362 (1960)
  53. Drew RH, "Is it time to abandon the use of amphotericin B bladder irrigation?", Clin Infect Dis, 40, pp.1465~1470 (2005)
  54. Agustin J, "Failure of a lipid amphotericin B preparation to eradicate candiduria : preliminary findings based on three cases", Clin Infect Dis, 29, pp.686~687 (1999)
  55. Wise GJ, "How to diagnose and treat fungal infections in chronic prostatitis", Curr Urol Rep, 7, pp.320~328 (2006)
  56. Bartkowski DP, "Emphysematous prostatitis and cystitis secondary to Candida albicans", J Urol, 139, pp.1063~1065 (1988)
  57. Giannopoulos A, "Epididymitis caused by Candida glabrata: a novel infection in diabetic patients?", Diabetes Care, 24, pp.2003~2004 (2001)
  58. Jenkin GA, "Candidal epididymoorchitis : case report and review", Clin Infect Dis, 26, pp.942~945 (1998)
  59. Fisher J, "Fungus balls of the urinary tract", South Med J, 72, pp.1281~1284 (1979)
  60. Chung BH, "Successfully treated renal fungal ball with continuous irrigation of fluconazole", J Urol, 166, pp.1835~1836 (2001)
  61. Bartone FF, "The role of percutaneous nephrostomy in the management of obstructing candidiasis of the urinary tract in infants", J Urol, 140, pp.338~341 (1988)
  62. Chitale SV, "Endoscopic management of renal candidiasis", J Endourol, 18, pp.865~866 (2004)
  63. Kabaalioğlu A, "Renal candidiasis in a 2-month-old infant : treatment of fungus balls with streptokinase", AJR Am J Roentgenol, 176, pp.511~512 (2001)
  64. Fisher JF, "Efficacy of a single intravenous dose of amphotericin B for Candida urinary tract infections : further favorable experience", Clin Microbiol Infect, 9, pp.1024~1027 (2003)

관련 논문AI추천

Candida 종에 의한 병원-획득성 요로감염에서 위험인자 분석김태형, 이미경, 정대성대한의진균학회 · 대한의진균학회지2007 · 제12권 제3호Comparison of Monomicrobial versus Polymicrobial Candiduria: Time to Awareness of Candiduria김태형, 이미경, Hyunji Kim대한요로생식기감염학회 · Urogenital Tract Infection2019 · 제14권 제1호칸디다뇨의 역학과 치료우준희, 이은정, 정진원대한의진균학회 · 대한의진균학회지2008 · 제13권 제3호Blood Stream Infections by Candida glabrata and Candida krusei: A Single-Center Experience김명수, 김준명, 김창오, 송영구, 이한성, 정수진, 진범식, 최석훈, 최준용, 최희경, 한상훈대한내과학회 · The Korean Journal of Internal Medicine2009 · 제24권 제3호2011-2013년 카테터 유무에 따른 요로에서 분리된 효모의 양상권오주, 김태형, 류재형, 이미경대한요로생식기감염학회 · Urogenital Tract Infection2014 · 제9권 제2호Asymptomatic Bacteriuria in Older Adults – Diagnosis, Management, and Future Directions: A Narrative ReviewHee Jo Yang, Ki Hong Kim대한요로생식기감염학회 · Urogenital Tract Infection2025 · 제20권 제2호

이 간행물의 다른 논문 (5건)

Risk Factor Associated with Recurrence after OM-89 (Uro-Vaxom®) Treatment for Female Recurrent CystitisJi-Yeon Hanpp. 42-45How Women Evaluate Syndromic Recurrent Urinary Tract Infections김웅빈, 김영호, 이상욱, 이광우, Jun Mo Kim, Min Eui Kimpp. 46-54Gabapentin for the Treatment of Chronic Pelvic Pain Syndrome in Patients with High Pain ScoreIn-Rae Cho, 조석pp. 55-59Recurrent Urinary Tract Infection from Urethral Mesh Erosion after Midurethral Mesh Sling SurgeryJi-Yeon Hanpp. 60-63GRADE (Grading of Recommendations, Assessment, Development and Evalua-tion): “근거수준(Quality of Evidence)” 이란 무엇이며, 임상의사에게 왜 중요한가?Jae Hung Jung, Eu Chang Hwang, 정현진, 강호원, 구자윤, Hong Wook Kim, Do Kyung Kimpp. 64-70
원문 보기